• Slider Image
  • Slider Image
  • Slider Image

In the Press

May 10, 2018

We Need You: Join All of Us to Advance Precision Medicine

UC San Diego Health researchers call for volunteers to participate in landmark precision medicine research effort, including Dr. Razelle Kurzrock.


May 7, 2018

Non-Aspirin NSAIDs Offer No Survival Advantage in Metastatic RCC

This is the first such study in this group,with findings running counter to prior research in other cancers, with senior author of the study Dr. Rana McKay.


April 25, 2018

Breathe easier with lung cancer screenings

UC San Diego Health established a new lung cancer screening program to help current and former smokers determine their risk for lung cancer. The program is led by Dr. Mark Onaitis.


April 20, 2018

Keytruda Performs Well in Latest Lung Cancer Clinical Trials

The immunotherapy drug has been successful in treating other cancers and the latest trials provide hope for people battling lung cancer. The piece features Dr. Sandip Patel.


April 12, 2018

What You Need to Know About Head and Neck Cancer

Cancer.Net has a new blog about Head and Neck Cancer written by Dr. Kathryn Gold.


April 9, 2018

Cutting-edge cancer drug hobbled by diagnostic test confusion

Physicians struggle to identify which patients are likely to respond to a recently approved therapy, with input from Dr. Razelle Kurzrock.


April 5, 2018

Bryce Olson Wants To Raise Awareness About Precision Medicine. His Rallying Cry: 'Sequence Me'

Bryce Olson's story and collaboration with UC San Diego Moores Cancer Center is told in Forbes, featuring his collaboration team that includes Ida Deichaite, PhD, Director of Industry Relations, Pablo Tamayo, PhD, and Christina Jamieson, PhD.


April 2, 2018

Surprise! Medical Research a Big Winner in New Federal Budget

Despite the president’s threats to cut funding, Congress approved budget increases for cancer, Alzheimer’s, and other medical research. The article features research by Dr. Ezra Cohen.


April 2, 2018

Even DNA that Doesn’t Encode Genes Can Drive Cancer

A trove of previously overlooked genetic mutations play a role in cancer, providing nearly 200 new opportunities for molecularly targeted therapeutics, in a study by senior author Trey Ideker, PhD.


March 28, 2018

Local Realtors and restaurants team up for fundraiser

Local real estate agents and Conejo Valley restaurants are participating in an April effort to raise funds for research into a rare cancer of the gastrointestinal tract, one that has afflicted a 2017 Westlake High School graduate over the past year, and will support research being done by Dr. Jason Sicklick.


March 25, 2018

Expert Point of View: Ezra Cohen, MD, PhD

Discussant for the abstract, Dr. Ezra Cohen pointed out that although this subgroup may be responsive to checkpoint inhibition, it may not necessarily be anti–programmed cell death protein 1 (anti–PD-1) therapy.


March 20, 2018

Dr. Sacco on Ongoing Trials for Chemoradiation in Head and Neck Cancer

Assuntina G. Sacco, MD, assistant professor of medicine, medical oncologist, UC San Diego Health, discusses ongoing trials investigating chemoradiation for patients with head and neck cancer.


March 16, 2018

Comprehensive Breast Health Center Expands at UC San Diego Health

The Comprehensive Breast Health Center is located within the Koman Family Outpatient Pavilion at UC San Diego Health, and the facility offers women and men new options for breast cancer care.


March 9, 2018

Tissue-agnostic cancer drug pipeline grows, despite doubts

The FDA could soon approve the first drug developed explicitly for a tissue-agnostic cancer indication, but biological complexity may limit this approach. This Nature Review Drug Discovery article features Dr. Razelle Kurzrock.


March 9, 2018

UC San Diego Researchers Launch Combination Drug Trial to Eradicate B-Cell Malignancies

It’s hoped the two new drugs in tandem can fully clear leukemias and other blood cancers. This trial consists of PI Dr. Catriona Jamieson, was developed by Dr. Tom Kipps, and team member Dr. Michael Choi.


March 2, 2018

Watering Dandelions with Chemo Bath

UC San Diego Health milestone: 500 patients undergo HIPEC while ovarian cancer meets new foe, featuring HIPEC team members Drs. Andy Lowy, Jula Veerapong, Joel Baumgartner, and Kaitlyn Kelly.


March 1, 2018

Stand Up To Cancer dream team strives for ‘active interception’ of pancreatic cancer

The Stand Up To Cancer foundation has formed a “dream team” to identify new ways to detect pancreatic cancer at earlier stages when it is most amenable to treatment, which includes UC San Diego Moores Cancer Center.


March 1, 2018

Former SDSU Basketball Star Opens Up About Cancer Battle

Tammy Blackburn leads a jam-packed life with no desire to slow down for the "Big C." Her treatment is at UC San Diego Moores Cancer Center.


February 28, 2018

Not Enough People With HIV Receive Proper Cancer Treatment

Recognizing this threat to the health and longevity of the HIV population, the National Comprehensive Cancer Network (NCCN) has issued new guidelines on treating cancer among them, with Panel Co-Chair Dr. Erin Reid.


February 23, 2018

Cancer therapy poised for rapid advances, noted researcher says

Duane Roth Endowed Award Lecture recipient Dr, Carl June, a pioneer in CAR T cell therapy, presented information from research yet to be published pointing to advances in immunotherapy on Thursday February 22, 2018 at the Translational Oncology symposium.


February 23, 2018

Scripps Research CEO outlines path to financial sustainability

Translational Oncology Symposium Keynote Speaker Dr. Peter Schultz outlined progress towards financial independence within three to five years at the event on Thursday February 22, 2018.


» More Press


2018 Symposium


The 14th Moores Cancer Center Industry/Academia Translational Oncology Symposium was held on Thursday, February 22, 2018. See the Agenda here.

Duane Roth Award Lecture
Engineered T-Cells: The Sky is the Limit

Carl June, MD

Richard W. Vague Professor Of Immunotherapy
Perelman School Of Medicine
University Of Pennsylvania

Keynote Speaker
A New Model for Translational Research in the Nonprofit Sector

Peter Schultz, PhD

Chief Executive Officer
California Institute for Biomedical Research


Opening Remarks
Ida Deichaite, PhD, UC San Diego Moores Cancer Center

Mutational Signatures for Cancer Treatment and Cancer Prevention
Ludmil Alexandrov, PhD, UC San Diego Moores Cancer Center

Duane Roth Award Presenter
David Brenner, MD, Dean, UC San Diego SOM & Health Sciences

Junior Scientist Presentation: Dual PI3K/BRD4 Inhibition as a Novel Therapeutic Strategy for Hepatocellular Carcinoma
Adam Burgoyne, MD, PhD, UC San Diego Moores Cancer Center

The New Generation of Antibody Drug Conjugates: Intersection of Target and Payload
Julia Coronella, PhD, Tanabe Research Labs

Moores Cancer Center Overview
Ezra Cohen, MD, UC San Diego Moores Cancer Center

Symposium Introduction
Ida Deichaite, PhD, UC San Diego Moores Cancer Center

In silico drug discovery of dual inhibitors of combinatorial synthetic lethality inhibitors in the era of precision medical oncology; proof of concept
Donald Durden, MD, PhD, UC San Diego Moores Cancer Center

Role of neutrophil-mediated inflammation in colorectal cancer
Napoleone Ferrara, MD, UC San Diego Moores Cancer Center

A Personalized Cancer Immunotherapy Paradigm: Simple solutions to address complex options for patients
Priti Hedge, PhD, Genentech

The Next Wave: BCMA Targeted CAR-T Cells for Multiple Myeloma
Kristen Hege, MD, Celgene

Welcome Remarks
Pradeep Khosla, PhD, Chancellor, UC San Diego

Moores Cancer Center Introduction
Scott Lippman, MD, UC San Diego Moores Cancer Center

Inhibition of Difficult to Drug Tumor Cell and Immuno-Oncology targets with Next Generation Antisense Inhibitors
Robert MacLeod, PhD, Ionis Pharmaceuticals

Systematic Mapping of Genetic Vulnerabilities in Cancer via Novel CRISPR-Cas9 Screening Methodologies
Prashant Mali, PhD, UC San Diego Moores Cancer Center

Patient Advocacy Presentation
Brian McCloskey, Patient Advocate

Targeting PARP in Prostate Cancer: Promise and Pitfalls
Rana McKay, MD, UC San Diego Moores Cancer Center

Patient Advocacy Presentation
Bryce Olson, Patient Advocate

Gene Control Approach to Manipulate Cell State: Sensitizing Cancer Cells to Antibody-mediated Attack
Dave Orlando, PhD, Syros Pharmaceuticals

Killing Cancer Stem Cells in Brain Cancer
Jeremy Rich, MD, UC San Diego Moores Cancer Center



2017 Symposium



Take a look at featured talks from the past symposium.




2015 Symposium Slideshow



Thank you to all that came and participated in the 2015 Symposium - we hope you enjoy the memories!



2014 Translational Oncology Symposium

A decade of fostering collaborations, fueling innovation & saving lives



San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA. For the video, see below.



The article is available here.

  • Xconomy’s San Diego Life Sciences Roundup included Bob Klein’s Proposal presented at the Moores Cancer Center Symposium, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016.
         » Read Here
  • Xconomy's San Diego Life Sciences Roundup also included the Moores Cancer Center Symposium and Laura Esserman's acceptance of the Duane Roth Award.
         » Read Here
  • The San Diego Daily Transcript published an article about Dr. Esserman's acceptance of the Duane Roth Award and the Symposium.
         » Read Here
  • The San Diego Union Tribune wrote an article on the Symposium, namely the iSPY Trial and patient from the trial, San Diego Resident Heather Clark.
         » Read Here
  • Symposium Speaker Bob Klein was featured in a San Diego Union Tribune article, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016, presented at the Moores Cancer Center Symposium.
         » Read Here


Our Symposium Page




9th Symposium Featured on San Diego ABC 10 News




San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report from the 6PM News on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.

More In the Press